We hope this issue of ReFlections finds you safe and well, despite the ongoing hardships and challenges the COVID-19 pandemic is causing.
It is during such times
as these that we continue to see the value and benefit
the insurance industry provides to policyholders and
their families.
In this final edition of ReFlections for 2020, we bring you
articles written by three experienced and authoritative
RGA subject matter experts. Dr. Georgiana Willwerth-Pascutiu, Vice President, Global Medical Director,
walks us through the complex topic of cannabis, its
derivatives, its prevalence of use, and insurance industry
implications.
Hilary Henly, Head of Underwriting,
Ireland and Director, Divisional Underwriting Research,
provides a deep dive on e-cigarettes and the practice
of vaping, especially as it pertains to younger users,
and its health complications. Finally, Dr. Karneen Tam,
Medical Consultant, Asia Pacific, explains the concept of herd immunity – a very timely topic in the context of the
ongoing COVID-19 pandemic.
The Longer Life Foundation (LLF) update announces
the 2020-2021 grant award recipients and describes
the innovative research being funded. LLF is especially
proud to have provided an unprecedented interim
grant to Dr. Jeffrey Henderson, one of our alumni
grant recipients, to support his research: “Prognostic
Biomarkers of Severe Disease in COVID-19 Patients.”
As always, please be sure to check out ReCite for
highlights and RGA’s perspectives on recent medical
literature. Finally, we provide links to several new and
informative articles by our thought leaders that are
available on RGA’s Knowledge Center.
In this Issue
